| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 3.99e-05 | 7 | 29 | 2 | GO:0007221 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 3.14e-05 | 269 | 29 | 5 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 4.27e-05 | 287 | 29 | 5 | GO:0035770 | |
| GeneOntologyCellularComponent | chromatin | 6.93e-04 | 1480 | 29 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | nuclear body | 1.29e-03 | 903 | 29 | 6 | GO:0016604 | |
| HumanPheno | Progressive cerebellar ataxia | 1.05e-06 | 64 | 16 | 5 | HP:0002073 | |
| HumanPheno | Cerebellar ataxia | 1.42e-06 | 68 | 16 | 5 | HP:0001253 | |
| HumanPheno | Bradykinesia | 2.01e-05 | 116 | 16 | 5 | HP:0002067 | |
| HumanPheno | Rigidity | 2.88e-05 | 214 | 16 | 6 | HP:0002063 | |
| HumanPheno | Myoclonus | 6.61e-05 | 371 | 16 | 7 | HP:0001336 | |
| HumanPheno | Agitation | 7.65e-05 | 77 | 16 | 4 | HP:0000713 | |
| HumanPheno | Gliosis | 2.12e-04 | 100 | 16 | 4 | HP:0002171 | |
| HumanPheno | Neuronal loss in central nervous system | 2.34e-04 | 40 | 16 | 3 | HP:0002529 | |
| HumanPheno | Impaired smooth pursuit | 2.71e-04 | 42 | 16 | 3 | HP:0007772 | |
| HumanPheno | Shuffling gait | 2.71e-04 | 42 | 16 | 3 | HP:0002362 | |
| HumanPheno | Constipation | 3.05e-04 | 472 | 16 | 7 | HP:0002019 | |
| HumanPheno | Status epilepticus | 3.20e-04 | 207 | 16 | 5 | HP:0002133 | |
| HumanPheno | Recurrent maladaptive behavior | SMARCA2 CACNA1A GIGYF2 TCF20 SATB1 ATXN2 MN1 HCN1 POLG HTT SCAF4 | 3.22e-04 | 1293 | 16 | 11 | HP:5200241 |
| HumanPheno | Genetic anticipation | 3.29e-04 | 9 | 16 | 2 | HP:0003743 | |
| HumanPheno | Abnormally increased volition | 4.28e-04 | 869 | 16 | 9 | HP:5200263 | |
| HumanPheno | Restlessness | 4.85e-04 | 124 | 16 | 4 | HP:0000711 | |
| HumanPheno | Aggressive behavior | 5.32e-04 | 516 | 16 | 7 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 5.32e-04 | 516 | 16 | 7 | HP:0006919 | |
| HumanPheno | Gaze-evoked nystagmus | 6.04e-04 | 55 | 16 | 3 | HP:0000640 | |
| MousePheno | increased taurine level | 2.82e-05 | 5 | 24 | 2 | MP:0030635 | |
| Domain | Neuroggenic_mastermind-like_N | 6.98e-06 | 3 | 29 | 2 | IPR019082 | |
| Domain | MamL-1 | 6.98e-06 | 3 | 29 | 2 | SM01275 | |
| Domain | MamL-1 | 6.98e-06 | 3 | 29 | 2 | PF09596 | |
| Domain | Homeobox | 2.75e-05 | 234 | 29 | 5 | PF00046 | |
| Domain | HOMEOBOX_1 | 2.86e-05 | 236 | 29 | 5 | PS00027 | |
| Domain | HOX | 2.92e-05 | 237 | 29 | 5 | SM00389 | |
| Domain | Homeobox_dom | 3.04e-05 | 239 | 29 | 5 | IPR001356 | |
| Domain | HOMEOBOX_2 | 3.04e-05 | 239 | 29 | 5 | PS50071 | |
| Domain | - | 6.80e-05 | 283 | 29 | 5 | 1.10.10.60 | |
| Domain | Homeodomain-like | 1.44e-04 | 332 | 29 | 5 | IPR009057 | |
| Domain | - | 7.98e-04 | 27 | 29 | 2 | 1.10.260.40 | |
| Domain | ZnF_U1 | 9.21e-04 | 29 | 29 | 2 | SM00451 | |
| Domain | Znf_U1 | 9.21e-04 | 29 | 29 | 2 | IPR003604 | |
| Domain | Lambda_DNA-bd_dom | 9.21e-04 | 29 | 29 | 2 | IPR010982 | |
| Domain | Homeobox_CS | 2.93e-03 | 186 | 29 | 3 | IPR017970 | |
| Domain | RRM | 4.52e-03 | 217 | 29 | 3 | SM00360 | |
| Domain | RRM_dom | 5.13e-03 | 227 | 29 | 3 | IPR000504 | |
| Domain | RRM | 5.32e-03 | 230 | 29 | 3 | PS50102 | |
| Domain | - | 6.26e-03 | 244 | 29 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 7.30e-03 | 258 | 29 | 3 | IPR012677 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.24e-04 | 10 | 24 | 2 | MM15535 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.81e-04 | 12 | 24 | 2 | M27159 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.81e-04 | 12 | 24 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.81e-04 | 12 | 24 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.14e-04 | 13 | 24 | 2 | M47534 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.50e-04 | 14 | 24 | 2 | M27808 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.81e-04 | 76 | 24 | 3 | MM15520 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.29e-04 | 16 | 24 | 2 | M27121 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.18e-04 | 18 | 24 | 2 | MM14775 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.18e-04 | 20 | 24 | 2 | M27881 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 5.58e-04 | 96 | 24 | 3 | M27784 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 6.88e-04 | 23 | 24 | 2 | MM14954 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.14e-04 | 25 | 24 | 2 | M27880 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 9.50e-04 | 27 | 24 | 2 | M39545 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.02e-03 | 28 | 24 | 2 | M6177 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.04e-03 | 119 | 24 | 3 | M607 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.34e-03 | 32 | 24 | 2 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.34e-03 | 32 | 24 | 2 | M27900 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.42e-03 | 33 | 24 | 2 | M604 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.78e-03 | 37 | 24 | 2 | M27797 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.98e-03 | 39 | 24 | 2 | MM14604 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 2.29e-03 | 42 | 24 | 2 | M17541 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.87e-03 | 47 | 24 | 2 | M7946 | |
| Pathway | WP_RETT_SYNDROME | 2.99e-03 | 48 | 24 | 2 | M39759 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.99e-03 | 48 | 24 | 2 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.11e-03 | 49 | 24 | 2 | M618 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 4.33e-03 | 58 | 24 | 2 | M11980 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 4.33e-03 | 58 | 24 | 2 | M29616 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 4.78e-03 | 61 | 24 | 2 | M39540 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 5.09e-03 | 63 | 24 | 2 | M27862 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.41e-03 | 65 | 24 | 2 | M39682 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 5.41e-03 | 65 | 24 | 2 | MM15147 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 5.63e-03 | 431 | 24 | 4 | M39729 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 6.08e-03 | 69 | 24 | 2 | M46439 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.43e-03 | 71 | 24 | 2 | M27394 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 6.78e-03 | 1387 | 24 | 7 | M734 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.96e-03 | 74 | 24 | 2 | M616 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 7.32e-03 | 237 | 24 | 3 | M27786 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 8.10e-03 | 246 | 24 | 3 | M10189 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 8.49e-03 | 82 | 24 | 2 | M594 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 8.49e-03 | 82 | 24 | 2 | MM15922 | |
| Pubmed | 1.93e-14 | 23 | 29 | 6 | 9225980 | ||
| Pubmed | The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1). | 1.82e-08 | 7 | 29 | 3 | 10860780 | |
| Pubmed | 4.28e-08 | 418 | 29 | 7 | 34709266 | ||
| Pubmed | SMARCA2 GIGYF2 ZFHX3 TCF20 SATB1 ZFHX4 DCP1B ATXN2 SCAF4 TNRC6A | 1.30e-07 | 1429 | 29 | 10 | 35140242 | |
| Pubmed | 4.09e-07 | 183 | 29 | 5 | 36129980 | ||
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 6.71e-07 | 2 | 29 | 2 | 10873665 | |
| Pubmed | Relative atrophy of the flocculus and ocular motor dysfunction in SCA2 and SCA6. | 6.71e-07 | 2 | 29 | 2 | 15826995 | |
| Pubmed | 6.84e-07 | 83 | 29 | 4 | 28794006 | ||
| Pubmed | 9.13e-07 | 23 | 29 | 3 | 26002199 | ||
| Pubmed | 1.63e-06 | 103 | 29 | 4 | 32744500 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.83e-06 | 457 | 29 | 6 | 32344865 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 12386158 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 12539049 | ||
| Pubmed | dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1. | 2.01e-06 | 3 | 29 | 2 | 18166084 | |
| Pubmed | 2.44e-06 | 263 | 29 | 5 | 34702444 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.68e-06 | 774 | 29 | 7 | 15302935 | |
| Pubmed | 2.98e-06 | 274 | 29 | 5 | 34244482 | ||
| Pubmed | Expanded CAG Repeats in ATXN1, ATXN2, ATXN3, and HTT in the 1000 Genomes Project. | 4.02e-06 | 4 | 29 | 2 | 33159825 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 23300874 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 20181956 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 11804332 | ||
| Pubmed | Spinocerebellar ataxias: microsatellite and allele frequency in unaffected and affected individuals. | 6.70e-06 | 5 | 29 | 2 | 20069235 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 7.63e-06 | 908 | 29 | 7 | 19274049 | |
| Pubmed | 9.37e-06 | 347 | 29 | 5 | 17114649 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 9.90e-06 | 351 | 29 | 5 | 38297188 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 16389595 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 8896557 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 14756671 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 16115810 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 2.12e-05 | 1489 | 29 | 8 | 28611215 | |
| Pubmed | 2.21e-05 | 1497 | 29 | 8 | 31527615 | ||
| Pubmed | 2.24e-05 | 709 | 29 | 6 | 22988430 | ||
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 12370315 | ||
| Pubmed | Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia. | 3.01e-05 | 10 | 29 | 2 | 19235102 | |
| Pubmed | The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study. | 3.01e-05 | 10 | 29 | 2 | 19259763 | |
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 3.38e-05 | 75 | 29 | 3 | 37298722 | |
| Pubmed | Meta-analysis identifies six new susceptibility loci for atrial fibrillation. | 4.41e-05 | 12 | 29 | 2 | 22544366 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 4.66e-05 | 1203 | 29 | 7 | 29180619 | |
| Pubmed | 6.23e-05 | 92 | 29 | 3 | 20301317 | ||
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 26184334 | ||
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 7.29e-05 | 97 | 29 | 3 | 37151849 | |
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 9417904 | ||
| Pubmed | Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo. | 8.00e-05 | 16 | 29 | 2 | 22069191 | |
| Pubmed | 8.35e-05 | 549 | 29 | 5 | 38280479 | ||
| Pubmed | 8.57e-05 | 282 | 29 | 4 | 23667531 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 9.62e-05 | 922 | 29 | 6 | 27609421 | |
| Pubmed | 1.22e-04 | 963 | 29 | 6 | 28671696 | ||
| Pubmed | 1.26e-04 | 20 | 29 | 2 | 35177643 | ||
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 1.36e-04 | 318 | 29 | 4 | 16919269 | |
| Pubmed | 1.55e-04 | 1006 | 29 | 6 | 15226823 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 1.94e-04 | 349 | 29 | 4 | 25665578 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.12e-04 | 139 | 29 | 3 | 16985003 | |
| Pubmed | The candidate splicing factor Sfswap regulates growth and patterning of inner ear sensory organs. | 2.15e-04 | 26 | 29 | 2 | 24391519 | |
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 2.25e-04 | 142 | 29 | 3 | 11812828 | |
| Pubmed | 2.33e-04 | 27 | 29 | 2 | 20301402 | ||
| Pubmed | 2.50e-04 | 28 | 29 | 2 | 29365100 | ||
| Pubmed | 2.75e-04 | 152 | 29 | 3 | 34299191 | ||
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 2.75e-04 | 152 | 29 | 3 | 28192407 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 3.03e-04 | 724 | 29 | 5 | 36232890 | |
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | 3.89e-04 | 419 | 29 | 4 | 33001583 | |
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 4.37e-04 | 178 | 29 | 3 | 27637333 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 4.39e-04 | 37 | 29 | 2 | 25798587 | |
| Pubmed | ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2. | 4.63e-04 | 38 | 29 | 2 | 30629181 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 4.96e-04 | 186 | 29 | 3 | 33637726 | |
| Pubmed | 5.00e-04 | 808 | 29 | 5 | 20412781 | ||
| Pubmed | 5.93e-04 | 43 | 29 | 2 | 36950384 | ||
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 6.31e-04 | 202 | 29 | 3 | 33601422 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 6.66e-04 | 861 | 29 | 5 | 36931259 | |
| Pubmed | 6.79e-04 | 46 | 29 | 2 | 34815492 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 7.24e-04 | 877 | 29 | 5 | 20211142 | |
| Pubmed | 7.71e-04 | 49 | 29 | 2 | 31762063 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 8.08e-04 | 220 | 29 | 3 | 35785414 | |
| Pubmed | 8.08e-04 | 220 | 29 | 3 | 24550385 | ||
| Interaction | KDM1A interactions | 4.18e-07 | 941 | 29 | 10 | int:KDM1A | |
| Interaction | PAX9 interactions | 1.08e-06 | 130 | 29 | 5 | int:PAX9 | |
| Interaction | TLX3 interactions | 3.09e-06 | 291 | 29 | 6 | int:TLX3 | |
| Interaction | TLX1 interactions | 4.68e-06 | 175 | 29 | 5 | int:TLX1 | |
| Interaction | HNF1B interactions | 6.98e-06 | 190 | 29 | 5 | int:HNF1B | |
| Interaction | ISX interactions | 1.17e-05 | 31 | 29 | 3 | int:ISX | |
| Interaction | GOLGA6L5P interactions | 1.20e-05 | 4 | 29 | 2 | int:GOLGA6L5P | |
| Interaction | TLE3 interactions | 1.34e-05 | 376 | 29 | 6 | int:TLE3 | |
| Interaction | TBXT interactions | 2.21e-05 | 116 | 29 | 4 | int:TBXT | |
| Interaction | NUP35 interactions | 2.64e-05 | 424 | 29 | 6 | int:NUP35 | |
| Interaction | PAX7 interactions | 2.88e-05 | 124 | 29 | 4 | int:PAX7 | |
| Interaction | TNRC6B interactions | 4.67e-05 | 282 | 29 | 5 | int:TNRC6B | |
| Interaction | TLX2 interactions | 4.89e-05 | 142 | 29 | 4 | int:TLX2 | |
| Interaction | CPEB1 interactions | 5.45e-05 | 146 | 29 | 4 | int:CPEB1 | |
| Interaction | SP7 interactions | 6.67e-05 | 304 | 29 | 5 | int:SP7 | |
| Interaction | CPEB4 interactions | 7.06e-05 | 156 | 29 | 4 | int:CPEB4 | |
| Interaction | SOX6 interactions | 7.23e-05 | 157 | 29 | 4 | int:SOX6 | |
| Interaction | SOX5 interactions | 8.17e-05 | 162 | 29 | 4 | int:SOX5 | |
| Interaction | GLDC interactions | 8.62e-05 | 321 | 29 | 5 | int:GLDC | |
| Interaction | ZYX interactions | 9.68e-05 | 329 | 29 | 5 | int:ZYX | |
| Interaction | MAGEB6 interactions | 1.09e-04 | 11 | 29 | 2 | int:MAGEB6 | |
| Interaction | TEAD1 interactions | 1.13e-04 | 176 | 29 | 4 | int:TEAD1 | |
| Interaction | VSX1 interactions | 1.15e-04 | 66 | 29 | 3 | int:VSX1 | |
| Interaction | PHF21A interactions | 1.18e-04 | 343 | 29 | 5 | int:PHF21A | |
| Interaction | HDAC1 interactions | 1.24e-04 | 1108 | 29 | 8 | int:HDAC1 | |
| Interaction | ZFP36 interactions | 1.25e-04 | 181 | 29 | 4 | int:ZFP36 | |
| Interaction | LHX2 interactions | 1.31e-04 | 183 | 29 | 4 | int:LHX2 | |
| Interaction | CLTB interactions | 1.36e-04 | 185 | 29 | 4 | int:CLTB | |
| Interaction | FOXP2 interactions | 1.37e-04 | 70 | 29 | 3 | int:FOXP2 | |
| Interaction | GATA3 interactions | 1.42e-04 | 187 | 29 | 4 | int:GATA3 | |
| Interaction | PYHIN1 interactions | 1.44e-04 | 358 | 29 | 5 | int:PYHIN1 | |
| Interaction | ZFHX4 interactions | 1.56e-04 | 73 | 29 | 3 | int:ZFHX4 | |
| Interaction | GATA2 interactions | 1.81e-04 | 199 | 29 | 4 | int:GATA2 | |
| Interaction | FEV interactions | 1.95e-04 | 203 | 29 | 4 | int:FEV | |
| Interaction | VAX2 interactions | 2.08e-04 | 15 | 29 | 2 | int:VAX2 | |
| Interaction | SOX7 interactions | 2.20e-04 | 82 | 29 | 3 | int:SOX7 | |
| Interaction | IRF4 interactions | 2.44e-04 | 85 | 29 | 3 | int:IRF4 | |
| Interaction | DPRX interactions | 3.02e-04 | 18 | 29 | 2 | int:DPRX | |
| Interaction | FOXI1 interactions | 3.09e-04 | 92 | 29 | 3 | int:FOXI1 | |
| Interaction | NIPSNAP1 interactions | 3.19e-04 | 231 | 29 | 4 | int:NIPSNAP1 | |
| Interaction | RNF43 interactions | 3.26e-04 | 427 | 29 | 5 | int:RNF43 | |
| Interaction | CSNK2A1 interactions | 3.29e-04 | 956 | 29 | 7 | int:CSNK2A1 | |
| Interaction | LMNB2 interactions | 3.35e-04 | 234 | 29 | 4 | int:LMNB2 | |
| Interaction | MTA2 interactions | 3.55e-04 | 435 | 29 | 5 | int:MTA2 | |
| Interaction | MIEN1 interactions | 3.74e-04 | 20 | 29 | 2 | int:MIEN1 | |
| Interaction | EYA4 interactions | 3.86e-04 | 243 | 29 | 4 | int:EYA4 | |
| Interaction | NOTCH4 interactions | 4.13e-04 | 21 | 29 | 2 | int:NOTCH4 | |
| Interaction | LHX1 interactions | 4.30e-04 | 103 | 29 | 3 | int:LHX1 | |
| Interaction | DCP1B interactions | 4.42e-04 | 104 | 29 | 3 | int:DCP1B | |
| Interaction | NINL interactions | 4.49e-04 | 458 | 29 | 5 | int:NINL | |
| Interaction | CRX interactions | 4.57e-04 | 254 | 29 | 4 | int:CRX | |
| Interaction | RBPJ interactions | 4.57e-04 | 254 | 29 | 4 | int:RBPJ | |
| Interaction | FOXP1 interactions | 4.70e-04 | 256 | 29 | 4 | int:FOXP1 | |
| Interaction | ZFHX3 interactions | 5.08e-04 | 109 | 29 | 3 | int:ZFHX3 | |
| Interaction | RBM12 interactions | 5.21e-04 | 110 | 29 | 3 | int:RBM12 | |
| Interaction | SULT1C4 interactions | 5.21e-04 | 110 | 29 | 3 | int:SULT1C4 | |
| Interaction | TBR1 interactions | 5.64e-04 | 113 | 29 | 3 | int:TBR1 | |
| Interaction | TSPOAP1 interactions | 5.88e-04 | 25 | 29 | 2 | int:TSPOAP1 | |
| Interaction | RCOR1 interactions | 6.33e-04 | 494 | 29 | 5 | int:RCOR1 | |
| Interaction | RNF4 interactions | 6.46e-04 | 1412 | 29 | 8 | int:RNF4 | |
| Interaction | TNRC6A interactions | 6.59e-04 | 280 | 29 | 4 | int:TNRC6A | |
| Interaction | SOX2 interactions | 6.77e-04 | 1422 | 29 | 8 | int:SOX2 | |
| Interaction | DDX6 interactions | 6.87e-04 | 503 | 29 | 5 | int:DDX6 | |
| Interaction | ATXN2L interactions | 7.13e-04 | 286 | 29 | 4 | int:ATXN2L | |
| Interaction | MARF1 interactions | 8.10e-04 | 128 | 29 | 3 | int:MARF1 | |
| Interaction | SMG7 interactions | 1.07e-03 | 319 | 29 | 4 | int:SMG7 | |
| Cytoband | 16q22.3 | 1.73e-05 | 10 | 29 | 2 | 16q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 1.42e-03 | 353 | 29 | 3 | chr12p13 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.40e-13 | 25 | 20 | 6 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.21e-04 | 15 | 20 | 2 | 529 | |
| GeneFamily | RNA binding motif containing | 2.28e-02 | 213 | 20 | 2 | 725 | |
| Coexpression | GUO_HEX_TARGETS_UP | 1.63e-06 | 78 | 29 | 4 | M1436 | |
| Coexpression | GUO_HEX_TARGETS_UP | 1.80e-06 | 80 | 29 | 4 | MM626 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 2.46e-06 | 199 | 29 | 5 | M6987 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | 5.91e-05 | 942 | 29 | 7 | M8144 | |
| Coexpression | VEGF_A_UP.V1_UP | 6.10e-05 | 195 | 29 | 4 | M2676 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 6.34e-05 | 197 | 29 | 4 | M9862 | |
| Coexpression | GSE17721_LPS_VS_CPG_0.5H_BMDC_UP | 6.47e-05 | 198 | 29 | 4 | M3982 | |
| Coexpression | GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 6.60e-05 | 199 | 29 | 4 | M8622 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 6.60e-05 | 199 | 29 | 4 | M9180 | |
| Coexpression | GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN | 6.60e-05 | 199 | 29 | 4 | M9195 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 6.60e-05 | 199 | 29 | 4 | M6964 | |
| Coexpression | GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN | 6.73e-05 | 200 | 29 | 4 | M3755 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP | 6.73e-05 | 200 | 29 | 4 | M5168 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | 9.85e-05 | 429 | 29 | 5 | M45694 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN | 1.01e-04 | 222 | 29 | 4 | M16955 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON | 1.40e-04 | 16 | 29 | 2 | M39025 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.47e-04 | 467 | 29 | 5 | M1347 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 1.67e-04 | 97 | 29 | 3 | M14698 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.73e-04 | 484 | 29 | 5 | MM999 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | 1.78e-04 | 778 | 29 | 6 | M17915 | |
| Coexpression | DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP | 1.79e-04 | 258 | 29 | 4 | M4680 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBM | 2.99e-04 | 295 | 29 | 4 | M39063 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CHONDROCYTES_AND_OSTEOBLASTS | 4.39e-04 | 28 | 29 | 2 | MM3665 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN | 5.04e-04 | 30 | 29 | 2 | M16101 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN | 5.04e-04 | 30 | 29 | 2 | MM1096 | |
| Coexpression | SIMBULAN_UV_RESPONSE_NORMAL_DN | 6.11e-04 | 33 | 29 | 2 | M16114 | |
| Coexpression | BENPORATH_NANOG_TARGETS | 6.37e-04 | 988 | 29 | 6 | M6616 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 6.54e-04 | 363 | 29 | 4 | M6315 | |
| Coexpression | GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | 6.62e-04 | 155 | 29 | 3 | M8913 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 7.16e-04 | 372 | 29 | 4 | MM1043 | |
| Coexpression | GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP | 7.53e-04 | 162 | 29 | 3 | M8903 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN | 7.53e-04 | 162 | 29 | 3 | M7002 | |
| Coexpression | GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP | 8.51e-04 | 169 | 29 | 3 | M5661 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 9.25e-04 | 174 | 29 | 3 | M45676 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 1.12e-03 | 186 | 29 | 3 | M4911 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 1.15e-03 | 1106 | 29 | 6 | M39071 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 1.15e-03 | 734 | 29 | 5 | M3835 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 1.21e-03 | 191 | 29 | 3 | M40019 | |
| Coexpression | GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN | 1.21e-03 | 191 | 29 | 3 | M4922 | |
| Coexpression | OSMAN_BLADDER_CANCER_DN | 1.24e-03 | 431 | 29 | 4 | M16858 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP | 1.25e-03 | 193 | 29 | 3 | M9056 | |
| Coexpression | GSE3982_NKCELL_VS_TH1_UP | 1.28e-03 | 195 | 29 | 3 | M5593 | |
| Coexpression | GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN | 1.30e-03 | 196 | 29 | 3 | M5504 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | 1.31e-03 | 438 | 29 | 4 | M227 | |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.32e-03 | 197 | 29 | 3 | M8983 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP | 1.32e-03 | 197 | 29 | 3 | M6226 | |
| Coexpression | GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.34e-03 | 198 | 29 | 3 | M5545 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN | 1.34e-03 | 198 | 29 | 3 | M5010 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN | 1.34e-03 | 198 | 29 | 3 | M4981 | |
| Coexpression | GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN | 1.34e-03 | 198 | 29 | 3 | M5861 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.36e-03 | 199 | 29 | 3 | M7259 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 1.36e-03 | 199 | 29 | 3 | M7596 | |
| Coexpression | GAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS | 1.36e-03 | 199 | 29 | 3 | M43608 | |
| Coexpression | GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN | 1.36e-03 | 199 | 29 | 3 | M4147 | |
| Coexpression | GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN | 1.36e-03 | 199 | 29 | 3 | M5874 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 1.36e-03 | 199 | 29 | 3 | M9255 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN | 1.36e-03 | 199 | 29 | 3 | M3912 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP | 1.36e-03 | 199 | 29 | 3 | M4886 | |
| Coexpression | GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.36e-03 | 199 | 29 | 3 | M9159 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN | 1.36e-03 | 199 | 29 | 3 | M9532 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.36e-03 | 199 | 29 | 3 | M5240 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | 1.38e-03 | 200 | 29 | 3 | M7294 | |
| Coexpression | GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN | 1.38e-03 | 200 | 29 | 3 | M7269 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 1.38e-03 | 200 | 29 | 3 | M9458 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP | 1.38e-03 | 200 | 29 | 3 | M6415 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN | 1.38e-03 | 200 | 29 | 3 | M7741 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_DN | 1.38e-03 | 200 | 29 | 3 | M3399 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_DN | 1.38e-03 | 200 | 29 | 3 | M5118 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP | 1.38e-03 | 200 | 29 | 3 | M3778 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP | 1.38e-03 | 200 | 29 | 3 | M3791 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN | 1.38e-03 | 200 | 29 | 3 | M9368 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 1.38e-03 | 200 | 29 | 3 | M6243 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN | 1.38e-03 | 200 | 29 | 3 | M8494 | |
| Coexpression | GSE6681_DELETED_FOXP3_VS_WT_TREG_DN | 1.38e-03 | 200 | 29 | 3 | M6779 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 1.38e-03 | 200 | 29 | 3 | M387 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 1.38e-03 | 200 | 29 | 3 | M5870 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN | 1.38e-03 | 200 | 29 | 3 | M9692 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN | 1.38e-03 | 200 | 29 | 3 | M7508 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN | 1.38e-03 | 200 | 29 | 3 | M8854 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN | 1.38e-03 | 200 | 29 | 3 | M6639 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_UP | 1.38e-03 | 200 | 29 | 3 | M5157 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN | 1.38e-03 | 200 | 29 | 3 | M8735 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP | 1.38e-03 | 200 | 29 | 3 | M9610 | |
| Coexpression | CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS | 1.40e-03 | 50 | 29 | 2 | M1702 | |
| Coexpression | XU_GH1_AUTOCRINE_TARGETS_UP | 1.40e-03 | 201 | 29 | 3 | M10664 | |
| Coexpression | BURTON_ADIPOGENESIS_11 | 1.46e-03 | 51 | 29 | 2 | MM1197 | |
| Coexpression | BURTON_ADIPOGENESIS_11 | 1.51e-03 | 52 | 29 | 2 | M1632 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 1.69e-03 | 55 | 29 | 2 | MM3666 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 8.40e-06 | 801 | 29 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.31e-05 | 107 | 29 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 7.38e-05 | 791 | 29 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 1.23e-04 | 71 | 29 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 1.64e-04 | 388 | 29 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 2.95e-04 | 989 | 29 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 3.38e-04 | 247 | 29 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 3.48e-04 | 249 | 29 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-07 | 200 | 29 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.32e-06 | 179 | 29 | 4 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.32e-06 | 179 | 29 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.81e-06 | 183 | 29 | 4 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.88e-06 | 191 | 29 | 4 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 192 | 29 | 4 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 7.62e-06 | 196 | 29 | 4 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.77e-06 | 197 | 29 | 4 | 51340570667914bffec741c72a8d09cc46abb8e8 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-06 | 198 | 29 | 4 | ea6621a148a96c8ffa1a93a35c9e288545d2637a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 156 | 29 | 3 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 164 | 29 | 3 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-04 | 165 | 29 | 3 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 165 | 29 | 3 | 1d0f60bf47a40ac916f0fcb5532a968742a0edbb | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.74e-04 | 168 | 29 | 3 | 07be11b6f0f37106e219692db5795c6dd32807c9 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-04 | 173 | 29 | 3 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-04 | 173 | 29 | 3 | f31e738c2b3b319fb40b0b16b2393a51c9a8999c | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.93e-04 | 174 | 29 | 3 | 268abfc4d53a3ba3931dbcafffef09a72ea0edfa | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.96e-04 | 175 | 29 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-04 | 175 | 29 | 3 | 0c648e7f67ffbe3b476a2ca77d246554f8cd1882 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.96e-04 | 175 | 29 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 176 | 29 | 3 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-04 | 177 | 29 | 3 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 178 | 29 | 3 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.06e-04 | 178 | 29 | 3 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 2.10e-04 | 179 | 29 | 3 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.13e-04 | 180 | 29 | 3 | 810c7116007ee6668d3731e7ce1fcf697c7b24f6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-04 | 180 | 29 | 3 | d553aba594f5304f1c09ff9c6d49b64cd7ee7850 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 2.20e-04 | 182 | 29 | 3 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 182 | 29 | 3 | f5f42e23832d0210560009ce6fd8eee89751e252 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 182 | 29 | 3 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 182 | 29 | 3 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 182 | 29 | 3 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 184 | 29 | 3 | 30fddbc9696476d4d7f08e53f84ea994a4ed873a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.27e-04 | 184 | 29 | 3 | 437bc6c983849c1c3ff85f0dee091cf7010a4665 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 184 | 29 | 3 | 96926efa220f03d0787322c9519bb9e8f64f74d0 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 184 | 29 | 3 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.27e-04 | 184 | 29 | 3 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.27e-04 | 184 | 29 | 3 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.27e-04 | 184 | 29 | 3 | d1d5dd1701dff4eedf1cebbb9f4cd603aa0009c1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-04 | 185 | 29 | 3 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 185 | 29 | 3 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-04 | 185 | 29 | 3 | fcd95bc074e982fc7b8fd48d2e80038b9ea35ebb | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 185 | 29 | 3 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-04 | 185 | 29 | 3 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 185 | 29 | 3 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 2.31e-04 | 185 | 29 | 3 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 186 | 29 | 3 | aeac0c2db173cd1ea45b5052ab418d6cacd198d8 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.35e-04 | 186 | 29 | 3 | fbc4ba4a7a8e5902a1b0add52ece0d6da85a8a5f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-04 | 186 | 29 | 3 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.35e-04 | 186 | 29 | 3 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.35e-04 | 186 | 29 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.35e-04 | 186 | 29 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.35e-04 | 186 | 29 | 3 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 187 | 29 | 3 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.42e-04 | 188 | 29 | 3 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.42e-04 | 188 | 29 | 3 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-04 | 188 | 29 | 3 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.42e-04 | 188 | 29 | 3 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-04 | 189 | 29 | 3 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-04 | 189 | 29 | 3 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.50e-04 | 190 | 29 | 3 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.54e-04 | 191 | 29 | 3 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.54e-04 | 191 | 29 | 3 | f398344aaa79fc93d792e241b634a6afe4aff33d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.54e-04 | 191 | 29 | 3 | 11da47d96f44ba629e3299667495e7daddbbe86c | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 191 | 29 | 3 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-04 | 191 | 29 | 3 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | COVID-19_Moderate-CD8+_T_naive|World / disease group, cell group and cell class | 2.54e-04 | 191 | 29 | 3 | c3385226915097f47d2f197166fc755227438524 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.54e-04 | 191 | 29 | 3 | ffcb2c8dbcf40281b439f4b719b5b341972ffb9a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.54e-04 | 191 | 29 | 3 | 509d17d8ee0d028757ce0f2c9b97e5875f06f0ab | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-04 | 191 | 29 | 3 | fda432a7f79664e8ffd5d03c1c69ec43bbac994b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.54e-04 | 191 | 29 | 3 | ffe88d1ad676c745c76db89f766062fd365329f4 | |
| ToppCell | remission-CD4+_T_naive|World / disease stage, cell group and cell class | 2.58e-04 | 192 | 29 | 3 | 4bd94ce876d70f93dbdfad1dcd09e1468213cf57 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-04 | 192 | 29 | 3 | 32927ef3b93e0497e9bbe63c2754da03cf178202 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-04 | 192 | 29 | 3 | ef8970e5389bd55c1624cd6dd01a7ca7abaa8950 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 2.58e-04 | 192 | 29 | 3 | ad7207810116e73d461242e42071901b6a9f48c6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 192 | 29 | 3 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Endothelial-Endothelial-B|Endothelial / shred on cell class and cell subclass (v4) | 2.58e-04 | 192 | 29 | 3 | f8d7bd81e031d09a557722627c2f6180811cc6ab | |
| ToppCell | remission-CD4+_T_naive|remission / disease stage, cell group and cell class | 2.58e-04 | 192 | 29 | 3 | d96b2122e28c735d8002ad6eb2d3d52c8e9ccf2b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-04 | 193 | 29 | 3 | 95f5611dd9583f339b7c9f52bb478af204fb89ad | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.66e-04 | 194 | 29 | 3 | 2e2019a7bf57f257f0ff9b24eacff59dbb952ebb | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.66e-04 | 194 | 29 | 3 | 8805c90e4284a81a6c8078f2d2417ae77b4e5c63 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.66e-04 | 194 | 29 | 3 | 86d52467b05a0018517377c9c441245501f71d91 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.66e-04 | 194 | 29 | 3 | c53478057674d70b79df8a3f476d15dea1925753 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.66e-04 | 194 | 29 | 3 | e0ccf18edbae09fc1068f1e923f1bc0d0ff44195 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD4+_T|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.66e-04 | 194 | 29 | 3 | 31a98ce929ee6cf6a9747e384f9a06336af49fd5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.66e-04 | 194 | 29 | 3 | fc0504730ae576ff46ba0bc9f585c53ab78d914c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.66e-04 | 194 | 29 | 3 | d788d5bd1e651706e7e2d54ada546a5e84f86ff0 | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_naive|Control / Disease group, lineage and cell class | 2.66e-04 | 194 | 29 | 3 | aabcd9f71d8ef54add5c46d8a3e226e3ae3ab124 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.66e-04 | 194 | 29 | 3 | 2ab3f75b795a0ee4fe0f8eeba33093fcc77935f5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.70e-04 | 195 | 29 | 3 | 497d4bfbc38bcafab37e8a9c20bc9141f2e78d2a | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.70e-04 | 195 | 29 | 3 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.70e-04 | 195 | 29 | 3 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | COVID-19_Moderate-CD4+_T_naive|World / disease group, cell group and cell class | 2.70e-04 | 195 | 29 | 3 | 38d65cf0895f7a99d789ec3dcbd56a7506706d38 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 195 | 29 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| Drug | glutamin | 1.41e-06 | 461 | 29 | 7 | CID000000738 | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.62e-06 | 197 | 29 | 5 | 1467_UP | |
| Drug | tamoxifen citrate; Up 200; 1uM; MCF7; HG-U133A | 4.86e-06 | 199 | 29 | 5 | 380_UP | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A | 4.98e-06 | 200 | 29 | 5 | 2175_DN | |
| Drug | neocarzinostatin chromophore | 2.90e-05 | 288 | 29 | 5 | CID000447545 | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; PC3; HT_HG-U133A | 9.87e-05 | 192 | 29 | 4 | 4487_DN | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; HL60; HG-U133A | 1.01e-04 | 193 | 29 | 4 | 1715_UP | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 3001_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A | 1.05e-04 | 195 | 29 | 4 | 1886_DN | |
| Drug | cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A | 1.07e-04 | 196 | 29 | 4 | 379_UP | |
| Drug | benserazide hydrochloride; Down 200; 10uM; SKMEL5; HG-U133A | 1.07e-04 | 196 | 29 | 4 | 631_DN | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 6605_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 7341_DN | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 2564_UP | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; HL60; HG-U133A | 1.09e-04 | 197 | 29 | 4 | 1726_UP | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 3247_UP | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 7437_DN | |
| Drug | SB 203580; Down 200; 1uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 7066_DN | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 5428_UP | |
| Drug | SB 202190; Up 200; 1uM; PC3; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 7058_UP | |
| Drug | 1,2,4-benzenetriol | 1.23e-04 | 76 | 29 | 3 | CID000010787 | |
| Disease | risk-taking behaviour | 3.83e-07 | 764 | 28 | 8 | EFO_0008579 | |
| Disease | smoking cessation | 5.24e-07 | 325 | 28 | 6 | EFO_0004319 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 5.47e-07 | 801 | 28 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | waist-hip ratio | 1.28e-05 | 1226 | 28 | 8 | EFO_0004343 | |
| Disease | smoking behavior | 1.58e-05 | 341 | 28 | 5 | EFO_0004318 | |
| Disease | dyslexia | 1.62e-05 | 162 | 28 | 4 | EFO_0005424 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.70e-05 | 346 | 28 | 5 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | chronic mucus hypersecretion | 1.82e-05 | 7 | 28 | 2 | EFO_0005673 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.16e-05 | 364 | 28 | 5 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | neutrophil count | 3.04e-05 | 1382 | 28 | 8 | EFO_0004833 | |
| Disease | Parkinson's disease (is_implicated_in) | 5.14e-05 | 76 | 28 | 3 | DOID:14330 (is_implicated_in) | |
| Disease | smoking status measurement | 8.17e-05 | 1160 | 28 | 7 | EFO_0006527 | |
| Disease | body fat percentage | 8.70e-05 | 488 | 28 | 5 | EFO_0007800 | |
| Disease | Tremor, Rubral | 1.03e-04 | 16 | 28 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.03e-04 | 16 | 28 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.03e-04 | 16 | 28 | 2 | C0278161 | |
| Disease | Abnormal coordination | 1.03e-04 | 16 | 28 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.03e-04 | 16 | 28 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 1.03e-04 | 16 | 28 | 2 | C0240991 | |
| Disease | alcohol consumption measurement | 1.25e-04 | 1242 | 28 | 7 | EFO_0007878 | |
| Disease | household income | 1.86e-04 | 304 | 28 | 4 | EFO_0009695 | |
| Disease | Parkinson disease | 1.98e-04 | 22 | 28 | 2 | cv:C0030567 | |
| Disease | age at first birth measurement | 2.00e-04 | 120 | 28 | 3 | EFO_0009101 | |
| Disease | age at menarche | 2.18e-04 | 594 | 28 | 5 | EFO_0004703 | |
| Disease | Ataxia | 2.57e-04 | 25 | 28 | 2 | C0004134 | |
| Disease | cannabis dependence | 2.82e-04 | 135 | 28 | 3 | EFO_0007191 | |
| Disease | longevity, healthspan, parental longevity | 3.47e-04 | 29 | 28 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | diet measurement | 3.83e-04 | 1049 | 28 | 6 | EFO_0008111 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 3.97e-04 | 31 | 28 | 2 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 4.31e-04 | 156 | 28 | 3 | C0235480 | |
| Disease | familial atrial fibrillation | 4.31e-04 | 156 | 28 | 3 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.31e-04 | 156 | 28 | 3 | C2585653 | |
| Disease | Atrial Fibrillation | 4.64e-04 | 160 | 28 | 3 | C0004238 | |
| Disease | Spinocerebellar Ataxia Type 2 | 4.78e-04 | 34 | 28 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 4.78e-04 | 34 | 28 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 4.78e-04 | 34 | 28 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 4.78e-04 | 34 | 28 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 4.78e-04 | 34 | 28 | 2 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 4.78e-04 | 34 | 28 | 2 | C0087012 | |
| Disease | carbohydrate intake measurement | 4.78e-04 | 34 | 28 | 2 | EFO_0010811 | |
| Disease | Spinocerebellar Ataxia Type 4 | 5.07e-04 | 35 | 28 | 2 | C0752122 | |
| Disease | Mitral valve prolapse | 5.36e-04 | 36 | 28 | 2 | HP_0001634 | |
| Disease | depressive symptom measurement | 6.67e-04 | 426 | 28 | 4 | EFO_0007006 | |
| Disease | birth weight, parental genotype effect measurement | 7.88e-04 | 192 | 28 | 3 | EFO_0004344, EFO_0005939 | |
| Disease | FEV/FEC ratio | 8.79e-04 | 1228 | 28 | 6 | EFO_0004713 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPQQQQQQQQQQQQQ | 2311 | O00555 | |
| HQQQQQQQPQQQPGE | 391 | Q4VCS5 | |
| PPPQQQQQQQQQQQQ | 356 | Q5SZQ8 | |
| QQQQQQQPPPAQQQP | 471 | Q2M2I8 | |
| QQQQQQQPQQQQPPP | 126 | Q14774 | |
| QQQQQQQQQQPPPPQ | 641 | Q96JK9 | |
| QQQQQQQQQQQQQPP | 176 | Q99700 | |
| QQQQQQQQQQQPPPP | 31 | Q9UGI6 | |
| PQPPQLQQQQQQQQQ | 61 | Q9UGI6 | |
| QQQQQQQQQQPPHPL | 71 | Q9UGI6 | |
| QQQQQQQQQQPQQPQ | 46 | P54098 | |
| QQQQPPPPQQQQQQQ | 291 | Q9P0K8 | |
| QQQQQQQQQQPSSQP | 656 | Q8IZL2 | |
| PPQTLHQQQQQQQQQ | 246 | Q8IZD4 | |
| QQQQQQQQQPQPPQP | 76 | Q92896 | |
| QQQQQQQQQQQQQPP | 26 | P42858 | |
| QQQPQQQVQQSQPPQ | 731 | O60741 | |
| QQQLPQQQQQQPPQQ | 1206 | Q6Y7W6 | |
| PQPQAPQQPQQQQQQ | 951 | O95104 | |
| QPPQQQPQQQQQPQQ | 291 | Q10571 | |
| QPQQQQQPQQQQQQH | 296 | Q10571 | |
| QQQQQQQQPQQQPPQ | 231 | P51531 | |
| QQQPQQQPPQPQTQQ | 236 | P51531 | |
| LQQQQQQQQQQPPPS | 186 | P78424 | |
| PPQQQQQQQQQQQQA | 36 | Q9BVH7 | |
| QQQQQQQQQQQQAPP | 596 | Q01826 | |
| PQFVIQQQPQPQQQQ | 346 | Q8IXK0 | |
| QQQPPPPQQQQQQQA | 1771 | Q86UP3 | |
| QQQQQQQQQQQPPPH | 506 | Q8TF68 | |
| QQQQQQQQQPGQGPA | 196 | Q8WV24 | |
| PQGTQQGQQQQQPQQ | 306 | Q9UGU0 | |
| QGQQQQQPQQQQHPS | 311 | Q9UGU0 | |
| NNQQPQQQQQQQQPQ | 91 | Q8NDV7 | |
| QQQQQQQQPQQQQPQ | 96 | Q8NDV7 | |
| QQQPQQQQPQQQPQP | 101 | Q8NDV7 | |
| QQQPQQQPQPQPQQQ | 106 | Q8NDV7 | |
| QQPQPQPQQQQPQQQ | 111 | Q8NDV7 | |
| PQQQQQQQQPQVQQP | 3196 | Q15911 |